Skip to main content

Table 4 Comparison between the two AML subgroups (responders and non-responders) according to their pretreatment METTL3 gene expression level

From: Methyltransferase-like 3 gene (METTL3) expression and prognostic impact in acute myeloid leukemia patients

METTL3 gene expression (pretreatment)


AML cases with low normalized METTL3 gene expression (n = 15)


AML cases with high normalized METTL3 gene expression (n = 25)


p value

Median (IQR)

2.28 (1.87–2.58)

9.58 (7.7–14.6)

z = 28.566

< 0.001**

  1. IQR interquartile range, z Mann–Whitney test, HS highly significant
  2. **p value < 0.001